新功能型乳酸菌诱导抗原特异性滤泡辅助性T细胞(Tfh)促进SIgA产生的分子免疫机制
批准号:
31972696
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
杨文涛
依托单位:
学科分类:
兽医免疫学
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
杨文涛
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
Tfh是一类新发现的CD4+T细胞亚群,其主要功能是参与生发中心形成,辅助B细胞产生抗体,参与体液免疫应答。目前,研究表明用乳酸菌作为口服疫苗载体预防禽流感病毒(AIV)有很好的应用前景。申请人已构建融合表达AIV保守抗原NP-M1-DCpep的乳酸菌,发现其免疫小鼠和雏鸡不仅能产生显著的特异性SIgA抗体,还有很好的保护效果,从而推测这与小鼠淋巴结中增加的Tfh有密切联系,但其机制有待深入揭示。据此,本项目拟利用流式细胞术、MHC肽四聚体、基因敲除小鼠和雏鸡模型等技术和手段,从新功能型乳酸菌调节DCs和特异性Tfh活化、介导特异性Tfh促进生发中心形成和抗体产生以及抗AIV感染效应等方面开展研究,以期阐明新功能型乳酸菌通过特异性Tfh诱导SIgA产生的免疫学机制,为基于新功能型乳酸菌的疫病免疫防控新策略提供理论依据。
英文摘要
Follicular helper T cells (Tfh), defined as subset of CD4+ T cells recently, were found critical role in germinal centers (GCs) formation, providing help to B cells for the production of antibodies and humoral immunity responses. At present, many reportes show that it is a very good prospect to use lactic acid bacteria as oral vaccine vector to prevent AIV. Our previously study confirmed that a novel lactic acid bacteria (nLAB) was constructed by using Lactobacillus plantarum to deliver AIV protective antigen (NP-M1) via specific dendritic cell-targeting peptides to dendritic cells (DCs), which elicited high levels of specific sIgA antibodies and induced robust protective immunity against AIV. The immune response induced by nLAB may associate with high number of Tfh in lymph node. However, the mechanism of this protection effect remains unclear. Therefore, the purpose of our research is to investigate the mechanism of how nLAB mediate Tfh cells to protect host under AIV challenge. We will evaluate and illustrate DCs, specific Tfh activity and differentiation, their influence on GC formation and production of antibodies. Flow cytometry, IAbNP MHCII tetramer and infection model of knockout mice and chickens will be implemented in our study. The aim is to understand the underlying mechanism of nLAB in inducing the production of SIgA by specific Tfh cells, and provide theoretical and experimental bases for developing new technology of immune prevention by nLAB.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1016/j.micpath.2023.106001
发表时间:2023
期刊:Microbial Pathogenesis
影响因子:--
作者:Xue-Yao Yang;Qing-Long Gong;Yan-Jin Li;Beshir Ata Emad;Man-Jie Hu;Yong-Yang Sun;Zhi-Yang Xue;Ying-Shi Yang;Xue-Pan Sun;Chun-Wei Shi;Gui-Lian Yang;Hai-Bin Huang;Yan-Long Jiang;Jian-Zhong Wang;Xin Cao;Nan Wang;Yan Zeng;Wen-Tao Yang;Chun-Feng Wang
通讯作者:Chun-Feng Wang
DOI:10.3389/fimmu.2021.800965
发表时间:2021
期刊:Frontiers in immunology
影响因子:7.3
作者:Niu H;Xing JH;Zou BS;Shi CW;Huang HB;Jiang YL;Wang JZ;Cao X;Wang N;Zeng Y;Yang WT;Yang GL;Wang CF
通讯作者:Wang CF
DOI:10.1016/j.micpath.2022.105924
发表时间:2022-12-15
期刊:MICROBIAL PATHOGENESIS
影响因子:3.8
作者:Niu,Tian -Ming;Yu,Ling-Jiao;Wang,Chun-Feng
通讯作者:Wang,Chun-Feng
DOI:10.1016/j.vetmic.2020.108834
发表时间:2020-10-01
期刊:VETERINARY MICROBIOLOGY
影响因子:3.3
作者:Li, Qiong-Yan;Xu, Man-Man;Wang, Chun-Feng
通讯作者:Wang, Chun-Feng
Improved pathogenicity of H9N2 subtype of avian influenza virus induced by mutations occurred after serial adaptations in mice
通过突变诱导的 H9N2 亚型禽流感病毒在小鼠体内进行一系列适应后,致病性提高。
DOI:10.1016/j.micpath.2021.105204
发表时间:2021-09-24
期刊:MICROBIAL PATHOGENESIS
影响因子:3.8
作者:Zhang, Rong-Rong;Yang, Xin;Wang, Chun-Feng
通讯作者:Wang, Chun-Feng
新功能型乳酸菌诱导肠道抗原特异性IgA+B细胞经“肠-肺轴”迁移的分子免疫机制研究
- 批准号:32373023
- 项目类别:面上项目
- 资助金额:50万元
- 批准年份:2023
- 负责人:杨文涛
- 依托单位:
国内基金
海外基金















{{item.name}}会员


